In Silico TRials guide optimal stratification of ATrIal FIbrillation patients to Catheter Ablation and pharmacological medicaTION: the i-STRATIFICATION study
Aims: Patients with persistent atrial fibrillation (AF) experience 50% recurrence despite pulmonary vein isolation (PVI), and no consensus is established for secondary treatments. The aim of our i-STRATIFICATION study is to provide evidence for stratifying patients with AF recurrence after PVI to op...
Váldodahkkit: | Dasí, A, Nagel, C, Pope, MTB, Wijesurendra, RS, Betts, TR, Sachetto, R, Loewe, A, Bueno-Orovio, A, Rodriguez, B |
---|---|
Materiálatiipa: | Journal article |
Giella: | English |
Almmustuhtton: |
Oxford University Press
2024
|
Geahča maid
-
What determines the optimal pharmacological treatment of atrial fibrillation? Insights from in silico trials in 800 virtual atria
Dahkki: Dasí, A, et al.
Almmustuhtton: (2023) -
In-silico trials with human modelling and simulation for guiding optimal stratification of atrial fibrillation patients to catheter ablation and pharmacological therapy
Dahkki: Dasí i Martinez, A
Almmustuhtton: (2023) -
Social stratification /
Dahkki: 246808 Jackson, J. A.
Almmustuhtton: (1968) -
Catheter Management and Risk Stratification of Patients With in Inpatient Treatment Due to Acute Epididymitis
Dahkki: Mike Wenzel, et al.
Almmustuhtton: (2020-12-01) -
A novel ecg−based biomarker quantifying apd restitution dispersion improves risk stratification following sotalol administration
Dahkki: Minchole, A, et al.
Almmustuhtton: (2012)